Why the study?
Does NT-proBNP correlate with pulmonary arterial pressure in COPD patients?
Does NT-proBNP correlate with pulmonary arterial pressure in COPD patients?
NT-proBNP significantly correlates with pulmonary arterial pressure in COPD patients, suggesting its potential utility as a non-invasive marker for detecting pulmonary hypertension.
May support NT-proBNP as non-invasive marker in COPD; leaves open prospective validation before practice change.
Background: Pulmonary hypertension is one of the cardiovascular complications of in COPD. However, a diagnosis of pulmonary hypertension requires an invasive test, such as right heart catheterization. NT-proBNP is a cardiac hormone that is elevated when a cardiac volume or pressure overload is present. It was hypothesized that NT-proBNP might play a role in detecting of pulmonary hypertension in COPD patients. Method: The 31 COPD patients, who underwent all of NT-proBNP, echocardiography, and spirometry in Seoul National University Bundang Hospital during the period from November 2003 to July 2005, were retrospectively analyzed. Result: Of the 31 COPD patients, 9 patients had pulmonary hypertension. A significant positive correlation was observed between the NT-proBNP and pulmonary arterial pressure (r=0.589, p=0.002). However, there was no significant correlation observed between the FEV1 and NT-proBNP and FEV1 and pulmonary arterial pressure. Conclusion: NT-proBNP might indicate the presence of pulmonary hypertension in COPD patients.
No takes yet. Share an insight, caveat, or question.
Hwang et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: